KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

These therapies combine the precision of antibody targeting with the efficacy of oligonucleotide-based therapeutics, representing a significant advancement in the treatment of challenging and rare ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the induction of high-affinity antibodies derived from GCs and produced by ...

Traditionally, antibody epitopes on target proteins have been identified by performing deletion ... Thus, in the ‘Simple Max’ method each residue is considered independently. To obtain aggregate ...

InnoCare and KeyMed will receive aggregate payments of up to $520 million ... and disruptive innovations across the biopharmaceutical and medical technologies sectors. ICP-B02 is a CD20×CD3 bispecific ...

Sjögren’s antibody testing is done using a blood sample. It checks antibody levels, including anti-SS-A (also called anti-Ro) and anti-SS-B (also called anti-La). Anti-SS-A and anti-SS-B are ...

Harmful infectious organisms are identified as invaders due to their antigens (distinct molecules on their surface). Each antibody produced by your immune system binds to a specific antigen and then ...